Physician

Christopher Robert Adam, MD

According to 2025 Medicare claims, Christopher Adam, MD (NPI: 1962821355) practices ophthalmology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Suffolk, NY. This provider's primary affiliated billing organization is OPHTHALMIC CONSULTANTS OF LONG ISLAND (NPI: 1245271600; TIN: 112498332) and primary practice location at 11733-4068. Adam is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Adam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,632 traditional Medicare patients, billed 41,080 HCPCS/CPT codes, and received $3,464,108 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 549 prescription claims across 170 beneficiaries totaling $72,503 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 44 records totaling $1,166. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,829 to $3,464,108. Similarly, Part D prescription costs have risen steadily, from $2,504 to $72,503. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.5M2018 Medicare payment: $2,829 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $20,433 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $940,297 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,716,812 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,064,047 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,133,201 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,464,108 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182437$2,829
201964136$20,433
20205713,498$940,297
20211,05010,295$2,716,812
20221,27514,360$3,064,047
20231,43728,765$3,133,201
20241,63241,080$3,464,108

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$36K$73K2015 Drug cost: $2,504 (USD; Tot_Drug_Cst)2016 Drug cost: $24,432 (USD; Tot_Drug_Cst)2017 Drug cost: $40,018 (USD; Tot_Drug_Cst)2018 Drug cost: $29,499 (USD; Tot_Drug_Cst)2019 Drug cost: $787 (USD; Tot_Drug_Cst)2020 Drug cost: $9,123 (USD; Tot_Drug_Cst)2021 Drug cost: $29,713 (USD; Tot_Drug_Cst)2022 Drug cost: $41,392 (USD; Tot_Drug_Cst)2023 Drug cost: $43,115 (USD; Tot_Drug_Cst)2024 Drug cost: $72,503 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151325$2,504
201653318$24,432
2017102572$40,018
201857387$29,499
2019N/R31$787
20204481$9,123
2021101268$29,713
2022111348$41,392
2023105317$43,115
2024170549$72,503

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more351818$113
67028Injection of drug into eye3381,681$108
92014Established patient complete exam of visual system1,2661,667$105
92134Imaging of retina9822,470$36
92250Photography of the retina1,0661,144$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium521,559$18,396
XiidraLifitegrast12480$10,870
Prednisolone AcetatePrednisolone Acetate1514,880$5,845
SimbrinzaBrinzolamide/Brimonidine Tart261,138$5,125
Brimonidine TartrateBrimonidine Tartrate351,665$1,350

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.44$1,166Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Christopher Robert Adam, MD?

Tedicare shows public-source Medicare data for Christopher Robert Adam, MD (NPI 1962821355), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Robert Adam, MD have ACO affiliation data?

Christopher Robert Adam, MD is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Christopher Robert Adam, MD?

Christopher Robert Adam, MD is linked to OPHTHALMIC CONSULTANTS OF LONG ISLAND (billing NPI 1245271600) in the available physician profile data.

Does Christopher Robert Adam, MD have Open Payments data?

Christopher Robert Adam, MD has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.